United States · FDA National Drug Code directory

Ligapar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44911-0477_c129ac7a-bc5e-4d72-939b-e77fe189f560
Product NDC
44911-0477
Form
LIQUID
Composition / generic term
Lappa Major, Ligament (Human), Cartilago Suis, Arnica Montana, Bryonia (Alba), Calcarea Phosphorica, Causticum, Rhododendron Chrysanthum, Rhus Tox, Ruta Graveolens, Silicea, Zincum Metallicum
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20181012
Source listing expiry
20261231

Source-listed ingredients

  • ARCTIUM LAPPA ROOT — 3 [hp_X]/mL
  • HUMAN LIGAMENT — 8 [hp_X]/mL
  • SUS SCROFA CARTILAGE — 8 [hp_X]/mL
  • ARNICA MONTANA WHOLE — 12 [hp_X]/mL
  • BRYONIA ALBA ROOT — 12 [hp_X]/mL
  • TRIBASIC CALCIUM PHOSPHATE — 12 [hp_X]/mL
  • CAUSTICUM — 12 [hp_X]/mL
  • RHODODENDRON AUREUM LEAF — 12 [hp_X]/mL
  • TOXICODENDRON PUBESCENS LEAF — 12 [hp_X]/mL
  • RUTA GRAVEOLENS FLOWERING TOP — 12 [hp_X]/mL
  • SILICON DIOXIDE — 12 [hp_X]/mL
  • ZINC — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (44911-0477-1) · 44911-0477-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →